Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
08 Jun 2015 Liver-Directed Therapy With SIRT, Using Y-90 Resin Microspheres, Plus FOLFOX-Based First-Line Chemotherapy for mCRC Gastrointestinal cancers
02 Jun 2015 Nivolumab vs Docetaxel in Advanced Non-Squamous Cell NSCLC Lung and other thoracic tumours - Immuno-oncology - Anticancer agents & Biologic therapy
30 May 2015 ESMO Press Release: ESMO Announces a Scale to Stratify the Magnitude of Clinical Benefit of Anti-Cancer Medicines
28 May 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Generic Bortezomib Haematologic malignancies - Anticancer agents & Biologic therapy
27 May 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Dinutiximab Cancer in Special Situations - Immuno-oncology
26 May 2015 European Medicines Agency Issues Positive Recommendation for a New Therapeutic Indication for Ibrutinib Haematologic malignancies - Anticancer agents & Biologic therapy
22 May 2015 The European Medicines Agency Recommends Granting a Marketing Authorisation for Pembrolizumab Melanoma - Immuno-oncology
22 May 2015 The European Medicines Agency Recommends Granting a Marketing Authorisation for Nivolumab in Squamous NSCLC Lung and other thoracic tumours - Immuno-oncology - Anticancer agents & Biologic therapy
22 May 2015 WHO Model List of Essential Medicines Revised Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
18 May 2015 Annals of Oncology Press Release: World First – Researchers Quantify the Proportion of Different Genetic Mutations Contained within Individual Bowel Cancers Gastrointestinal cancers
15 May 2015 Results of a study presented at the ESMO World Congress on Gastrointestinal Cancer 2014 and the ESMO Congress 2014 published in The New England Jour...
12 May 2015 Lower Radiation Doses May Be Sufficient For Treating Certain Cancers, Report IAEA Experts Bioethics, legal and economic issues
08 May 2015 IMPAKT 2015 News: Molecular Screening of Patients with Metastatic Breast Cancer Can Be Carried-Out Across EU Countries Breast cancer - Personalised medicine
07 May 2015 IMPAKT 2015 News: Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: A Circulating Tumour Cell Liquid Biopsy May Be Used for Non-Invasive Mutational Analysis in Patients with Breast Cancer Breast cancer - Translational research